ConductScience.org, home
NT-I7 for Kaposi Sarcoma in Patients With or Without HIV
API referenceFor AI assistants

Trial · NCT04893018

Adverse events100

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 100

Download this page as JSON
TypeEventOrgan systemGroupAffectedAt riskEvents
otherAnemiaBlood and lymphatic system disordersNT-I7 (Efineptakin Alfa) Dose Level 126
otherAnemiaBlood and lymphatic system disordersNT-I7 (Efineptakin Alfa) Dose Level 212
otherAxillary lymphadenopathyBlood and lymphatic system disordersNT-I7 (Efineptakin Alfa) Dose Level 106
otherAxillary lymphadenopathyBlood and lymphatic system disordersNT-I7 (Efineptakin Alfa) Dose Level 212
otherAnal painGastrointestinal disordersNT-I7 (Efineptakin Alfa) Dose Level 106
otherAnal painGastrointestinal disordersNT-I7 (Efineptakin Alfa) Dose Level 212
otherDiarrheaGastrointestinal disordersNT-I7 (Efineptakin Alfa) Dose Level 126
otherDiarrheaGastrointestinal disordersNT-I7 (Efineptakin Alfa) Dose Level 202
otherNauseaGastrointestinal disordersNT-I7 (Efineptakin Alfa) Dose Level 116
otherNauseaGastrointestinal disordersNT-I7 (Efineptakin Alfa) Dose Level 212
otherChillsGeneral disordersNT-I7 (Efineptakin Alfa) Dose Level 106
otherChillsGeneral disordersNT-I7 (Efineptakin Alfa) Dose Level 212
otherFatigueGeneral disordersNT-I7 (Efineptakin Alfa) Dose Level 116
otherFatigueGeneral disordersNT-I7 (Efineptakin Alfa) Dose Level 202
otherFeverGeneral disordersNT-I7 (Efineptakin Alfa) Dose Level 116
otherFeverGeneral disordersNT-I7 (Efineptakin Alfa) Dose Level 212
otherFlu like symptomsGeneral disordersNT-I7 (Efineptakin Alfa) Dose Level 106
otherFlu like symptomsGeneral disordersNT-I7 (Efineptakin Alfa) Dose Level 212
otherGeneralized edemaGeneral disordersNT-I7 (Efineptakin Alfa) Dose Level 106
otherGeneralized edemaGeneral disordersNT-I7 (Efineptakin Alfa) Dose Level 212

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04893018/events

API referenceFor AI assistants